Cardiology

Experimental antiplatelet compound for acute stroke shows promise

An experimental antiplatelet compound inhibited clot formation without increasing bleeding, a common and potentially dangerous side effect of current anticlotting therapies, according to new phase I research in Arteriosclerosis, ...

Cardiology

Clot buster use differs between black and white stroke patients

White stroke patients are much more likely than black patients to be treated in community hospital emergency departments with the clot-busting drug intravenous tissue-plasminogen activator, or tPA, according to preliminary ...

Cardiology

FDA warns of rare stroke risk with MS drug

(HealthDay)—A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food ...

page 5 from 19